رجوع
نطاق اليوم
KWD 41.32
KWD 41.32
نطاق 52 أسبوعًا
KWD 25.80
KWD 42.22
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 38.09
/
KWD 33.40
الإغلاق السابق
KWD 41.32
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 30.0 | 0.4 |
| P/B | 0.4 | 2.9 |
| ROE % | 1.2 | 3.8 |
| Net Margin % | 1.7 | 3.9 |
| Rev Growth 5Y % | 16.1 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 34.414
KWD 33.723 – KWD 35.140
|
48 B | 1 |
| FY2029 |
KWD 31.000
KWD 30.377 – KWD 31.654
|
45 B | 1 |
| FY2028 |
KWD 25.512
KWD 25.000 – KWD 26.050
|
40 B | 1 |
النقاط الرئيسية
Revenue grew 16.05% annually over 5 years — strong growth
Earnings declined -87.73% over the past year
ROE of 1.22% is below average
Debt/Equity of 0.31 — conservative balance sheet
Generating 8.50B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.83%
النمو
Revenue Growth (5Y)
16.05%
Revenue (1Y)8.22%
Earnings (1Y)-87.73%
FCF Growth (3Y)N/A
الجودة
Return on Equity
1.22%
ROIC12.20%
Net Margin1.69%
Op. Margin28.50%
الأمان
Debt / Equity
0.31
Current Ratio0.90
Interest Coverage9.68
التقييم
P/E Ratio
29.96
P/B Ratio0.38
EV/EBITDA3.11
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.22% | Revenue Growth (3Y) | 12.84% |
| Earnings Growth (1Y) | -87.73% | Earnings Growth (3Y) | -55.51% |
| Revenue Growth (5Y) | 16.05% | Earnings Growth (5Y) | -35.05% |
| Profitability | |||
| Revenue (TTM) | 28.17B | Net Income (TTM) | 476.80M |
| ROE | 1.22% | ROA | 0.71% |
| Gross Margin | 43.63% | Operating Margin | 28.50% |
| Net Margin | 1.69% | Free Cash Flow (TTM) | 8.50B |
| ROIC | 12.20% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.31 | Current Ratio | 0.90 |
| Interest Coverage | 9.68 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 29.96 | P/B Ratio | 0.38 |
| P/S Ratio | 0.51 | PEG Ratio | -2.67 |
| EV/EBITDA | 3.11 | Dividend Yield | 0.00% |
| Market Cap | 14.28B | Enterprise Value | 24.97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 28.17B | 26.03B | 22.12B | 18.79B | 15.53B |
| Net Income | 476.80M | 3.89B | 2.41B | 2.64B | 2.68B |
| EPS (Diluted) | 1.38 | 11.24 | 7.39 | 8.44 | 8.62 |
| Gross Profit | 12.29B | 20.24B | 17.13B | 14.01B | 12.05B |
| Operating Income | 8.03B | 5.63B | 4.07B | 3.81B | 3.73B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 67.26B | 75.44B | 74.03B | 52.50B | 48.66B |
| Total Liabilities | 29.64B | 35.15B | 40.16B | 25.97B | 25.46B |
| Shareholders' Equity | 37.62B | 40.29B | 33.87B | 26.53B | 23.20B |
| Total Debt | 11.72B | 16.74B | 20.49B | 9.10B | 10.91B |
| Cash & Equivalents | 1.04B | 1.14B | 904.00M | 1.36B | 1.05B |
| Current Assets | 14.49B | 13.16B | 12.67B | 11.21B | 8.78B |
| Current Liabilities | 16.03B | 12.60B | 19.10B | 14.86B | 8.76B |
درجات الاستراتيجيات
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026